RNS
UTHR icon

Robert N. Shapiro’s United Therapeutics UTHR Stock Holding History

Robert N. Shapiro’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-90
Closed -$8K – 870
2014
Q2 		$8K Hold
90
– – ﹤0.01% 645
2014
Q1 		$8K Buy
+90
New +$9.21K ﹤0.01% 646

Other funds holding UTHR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
AL
AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Robert N. Shapiro's UTHR Position: Q3 2014 in Review

Robert N. Shapiro sold out of United Therapeutics (UTHR) in Q3 2014, closing a stake of 90 shares — an estimated $8K sold.

Robert N. Shapiro first reported a position in UTHR in Q1 2014 and held it in 2 quarters. The position peaked at $8K in Q2 2014. 319 funds tracked by Wall St. Rank hold UTHR as of Q3 2014.

  • Robert N. Shapiro reported no remaining United Therapeutics position as of Q3 2014 after selling out during the quarter.
  • Robert N. Shapiro sold 90 United Therapeutics shares in Q3 2014, an estimated $8K.
  • Robert N. Shapiro first reported a position in United Therapeutics in Q1 2014 and held it in 2 quarters.
  • Robert N. Shapiro's United Therapeutics position peaked at $8K in Q2 2014.
  • 319 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2014.

Based on Robert N. Shapiro's 13F filing for Q3 2014, filed 21 Oct 2014.